close
close

Company logo

Company logo

Global Depyrogenated Sterile Empty Vials Market

Global Depyrogenated Sterile Empty Vials MarketGlobal Depyrogenated Sterile Empty Vials Market

Global Depyrogenated Sterile Empty Vials Market

Dublin, July 11, 2024 (GLOBE NEWSWIRE) — The report “Global Depyrogenated Sterile Empty Vials Market by Type (Glass Vial, Plastic Vial), Capacity (10ml, 20ml, 2ml), End User – Forecast 2024-2030” has been added to The Offer.

Depyrogenated Sterile Empty Vials Market size was estimated at USD 797.79 Million in 2023 and USD 846.93 Million in 2024 and is expected to grow at a CAGR of 6.67% to reach USD 1.25 Billion by 2030.

With the increasing need for products that ensure safe administration of medical treatments, due to regulatory standards and healthcare guidelines that emphasize patient safety, the need for dehydrated sterile empty vials is also increasing. However, the risk associated with the availability of counterfeit products is hampering the growth of the dehydrated sterile empty vials market. Moreover, advancements in sterilization and depyrogenation technologies are improving the safety and efficiency of the vials and offering more sustainable pharmaceutical production practices, thereby increasing the need for depyrogenated sterile empty vials across the globe.

In the Americas, particularly in the US and Canada, there is a strong demand for depyrogenated sterile empty vials, supported by a well-established pharmaceutical and biotechnology sector. The major reason for the demand is the increasing emphasis on safety and sterility in the manufacturing of drugs. The increasingly stringent drug safety regulations by the FDA in the US mandate the use of dehydrated vials to minimize the risk of pyrogen contamination in injectable drugs. Increased research and development activities and regional clinical trials are contributing significantly to the market growth.

In Asia Pacific, countries such as China, India and Japan are witnessing rapid growth in the healthcare sector, which is further fueled by increasing investments in healthcare infrastructure and a growing focus on local manufacturing of pharmaceuticals. The rising number of chronic diseases and a booming generic drug market, especially in India, require strict adherence to contamination-free drug delivery systems, which increases the need for depyrogenated sterile empty vials. Expansion in pharmaceutical production and an increase in pharmaceutical exports require adherence to international quality standards and are another major driver for the depyrogenated sterile empty vials market.

Europe has a well-established pharmaceutical market with advanced healthcare systems and a strong focus on research and innovation. Strict EU regulations on drug manufacturing and drug safety standards require the use of depyrogenated, sterile, empty vials, especially for injectable drugs. The presence of numerous pharmaceutical companies and a highly developed healthcare infrastructure supports the use of these vials. In the Middle East and Africa, rising healthcare spending, construction of new pharmaceutical factories and government initiatives to strengthen the healthcare sector are increasing the need for these vials.

Key market dynamics

Market leader

Market restrictionsLack of health infrastructure

Market opportunities

Market challenges

Market segmentation analysis

Industry insights

  • Market disruption analysis

  • Porter’s Five Forces Analysis

  • Value chain and critical path analysis

  • Price analysis

  • Technology analysis

  • Patent analysis

  • Trading Analysis

  • Analysis of the regulatory framework

Recent developments

ALK Life Science Solutions enters into strategic partnership with Galenova for the distribution of pyrogen-free, sterile, empty vials

ALK Life Science Solutions has entered into a distribution agreement with Galenova, a key distributor in the Canadian market. The goal of the partnership is to leverage Galenova's robust distribution network across Canada and ensure an efficient and reliable supply of these important vials to meet the growing needs of healthcare and scientific research. This collaboration is an important step for ALK Life Science Solutions to expand its market presence and support healthcare providers with high-quality, specialty pharmaceuticals.

Corning and SGD Pharma forge strategic alliance with new glass tubing plant

Corning Incorporated and SGD Pharma have announced the formation of a joint venture that includes the commissioning of a state-of-the-art glass tubing facility. The goal of the collaboration is to improve production capabilities for high-quality pharmaceutical glass tubing, which is critical for the manufacture of vials and other containers that meet the healthcare industry's stringent sterility standards. The new facility is expected to play a key role in improving supply chain efficiency for sterile and pyrogen-free vials and contribute to safer and more effective drug delivery systems.

Strategy analysis and recommendation

Strategic analysis is essential for companies seeking to gain a foothold in the global market. Companies are better able to make informed decisions that align with their long-term goals by thoroughly evaluating their current position in the Depyrogenated Sterile Empty Vials market. This critical assessment includes a thorough analysis of the company's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Important company profiles

The report covers the recent significant developments in the Depyrogenated Sterile Empty Vials market and highlights leading vendors and their innovative profiles. These include

  • Arab Pharmaceutical Glass Co. (APG)

  • Bormioli Pharma

  • Console glass

  • Corning

  • Gerresheimer

  • Global Pharmatech

  • Hindusthan National Glass & Industries

  • Nipro

  • Piramal Glass

  • SCHOTT

  • SGD Pharma

  • SGD SAS

  • Shandong Pharmaceutical Glass

  • Stevanato Group

  • Thermo Fisher Scientific

  • Triveni Polymers

  • West Pharmaceutical Services

  • YPSOMED

Key Features:

Report Attribute

details

Number of pages

182

Forecast period

2024 – 2030

Estimated market value (USD) in 2024

846.93 million US dollars

Projected market value (USD) until 2030

1253.88 million US dollars

Annual growth rate

6.6%

Regions covered

Generally

Market segmentation and coverage

This research report categorizes the Depyrogenated Sterile Empty Vials market to forecast revenues and analyze trends in each of the following submarkets:

Type

capacity

End user

  • Healthcare facilities

  • Pharmaceutical companies

  • Research & Academic Labs

For more information about this report visit https://www.researchandmarkets.com/r/eujmby

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Reply

Your email address will not be published. Required fields are marked *